 | WHO issues alert against substandard India-made drugs linked to deaths in UzbekistanThe WHO alert comes weeks after Uzbekistan said that 18 children died after consuming a syrup made by the company. |
 | Uzbekistan cough syrup case: Marion Biotech's production licence suspended; WHO issue alertIt said substandard medical products fail to meet quality standards or specifications and are therefore "out of specification." |
 | Cough syrup deaths in Uzbekistan: Noida firm stops syrup manufacturing 'for now', India begins probeMarion Biotech does not sell Dok-1 Max in India and its only export has been to Uzbekistan, an Uttar Pradesh government official said as inspection began at the company office in Noida. |
 | Cough syrup deaths: India seeks details from Uzbekistan on investigationsMEA spokesperson Arindam Bagchi said consular assistance is being provided to some linked to the company who are facing legal action there. |
 | Uzbekistan cough syrup deaths: Marion Biotech into pharma, nutraceuticals, cosmetic productsMarion Biotech is a licensed manufacturer and holds the licence for manufacturing Dok-1 Max syrup and tablet for exports granted by the Drugs Controller, Uttar Pradesh. |
 | Cough syrup linked deaths in Uzbekistan: Samples collected, Drugs control organisation initiates probeHasan Harris, legal representative of Mario Biotech, said the governments of both countries is looking into the matter and inquiring. |
 | Uzbekistan says 18 children dead after consuming India-made cough syrupUzbekistan’s Ministry of Health said 18 of 21 children took Doc-1 Max syrup, manufactured by Indian company Marion Biotech Private Limited, as they were suffering from an acute respiratory disease. |
 | Death of infants due to spurious cough syrup: SC dismisses J-K's plea against NHRC order on compensationTen children died in Ramnagar tehsil of Udhampur in December 2019 and January 2020 due to consumption of spurious cough syrup. |
 | Cough syrup deaths in Gambia serious issue, says WHO chief scientist Soumya SwaminathanSwaminathan was speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN). |
 | Indonesia bans sale of all syrup, liquid medication after death of 99 childrenAs many as 99 children died this year after taking syrup medicine containing ingredients linked to acute kidney injuries (AKI). |
 | Cough syrup tragedy evokes cry for tighter pharma checksLooking at the facts of the case, the company should never be around today. Maiden Pharma was blacklisted by Bihar in 2011 for selling cough syrup that failed local standards tests. |
 | Merchants of death in Indian pharma lethal for nationUnfortunately this is not the first such case, nor is likely to be the last. Vaccines made in haste indigenously during the pandemic had also exposed chinks in our armour. |
 | Cough syrups deaths: Govt panel says info shared by WHO so far inadequate to determine causeMentioning the observations, Dr Somani said, "The clinical features and the treatment received by the children as shared by WHO so far are inadequate to determine the aetiology. |
 | India in touch with Gambia over deaths linked to cough syrupExternal Affairs Minister S Jaishankar held a telephonic conversation with his Gambian counterpart Mamadou Tangara on Thursday, and conveyed "deepest condolences on the deaths of young children". |
 | Panel to analyse WHO report on Gambia child deaths linked to Indian cough syrups; Haryana halts productionThe committee will advise and recommend further action to India’s Drugs Controller General of India (DCGI) after the WHO submits all details. |
| Manufacturing, testing violations detected during inspection of Maiden Pharmaceuticals: Officials"Various documents were examined by the investigating team, which clearly indicates that the firm is not meeting the requirements of Drugs Rules, 1945 under Drugs and Cosmetics Act." |
| Haryana govt halts all drug production at factory linked to Gambia deaths"Taking cognisance of this, the state government has ordered that all drug production at this unit be stopped with immediate effect," Vij told PTI over phone. |
| Orders issued to halt drug manufacturing at Maiden Pharma's Sonipat unit: Haryana minister Anil VijThe report of the samples of four cough syrups which had been recently sent to the Central Drugs Laboratory in Kolkata for examination was awaited. |
| Govt panel formed to study WHO report on deaths of 66 Gambian kids linked to 4 Indian syrupsThe Central Drugs Standard Control Organisation took up the matter immediately with the Haryana State Regulatory Authority, under whose jurisdiction the drug manufacturing unit is located. |
| Grief and outrage in Gambia over cough syrup deathsSocial media has been swamped by criticism of the healthcare system and by photos of the children who have died, most of whom were aged under five. |
